| Nome |
# |
|
Neuronal and peripheral damages induced by synthetic psychoactive substances: an update of recent findings from human and animal studies, file e2f56ed8-baf4-3eaf-e053-3a05fe0a5d97
|
393
|
|
Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (S)-CE-123 on Mesocorticolimbic Dopamine System, file e2f56ed9-0387-3eaf-e053-3a05fe0a5d97
|
377
|
|
Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease, file e2f56ed9-88ab-3eaf-e053-3a05fe0a5d97
|
360
|
|
Direct and long-lasting effects elicited by repeated drug administration on 50-kHz ultrasonic vocalizations are regulated differently: Implications for the study of the affective properties of drugs of abuse, file e2f56ed3-f998-3eaf-e053-3a05fe0a5d97
|
231
|
|
Perinatal asphyxia: CNS development and deficits with delayed onset, file e2f56ed3-fafd-3eaf-e053-3a05fe0a5d97
|
206
|
|
A2A receptor antagonism and dyskinesia in Parkinson’s Disease, file e2f56ed3-ca34-3eaf-e053-3a05fe0a5d97
|
204
|
|
Role of movement in long-term basal ganglia changes: implications for abnormal motor responses, file e2f56ed3-b30c-3eaf-e053-3a05fe0a5d97
|
199
|
|
Involvement of Glutamate NMDA Receptors in the Acute, Long-Term, and Conditioned Effects of Amphetamine on Rat 50kHz Ultrasonic Vocalizations, file e2f56ed4-5379-3eaf-e053-3a05fe0a5d97
|
174
|
|
Influence of acute caffeine on 50-kHz ultrasonic vocalizations in male adult rats and relevance to caffeine-mediated psychopharmacological effects, file e2f56ed3-a01d-3eaf-e053-3a05fe0a5d97
|
136
|
|
Diabetes, a Contemporary Risk for Parkinson’s Disease: Epidemiological and Cellular Evidences, file e2f56ed8-940a-3eaf-e053-3a05fe0a5d97
|
112
|
|
The sweet road to Parkinson's disease, file e2f56ed8-2b1f-3eaf-e053-3a05fe0a5d97
|
106
|
|
Sensibilizzazione alla caffeina e sensibilizzazione all'amfetamina: influenza della suscettibilità individuale agli effetti della caffeina, file e2f56ed8-45bc-3eaf-e053-3a05fe0a5d97
|
106
|
|
Acute and long-term effects elicited by psychoactive drugs on 50-kHz ultrasonic vocalizations in rats: development of a new experimental tool for the study of drug-mediated reward., file e2f56ed4-51f3-3eaf-e053-3a05fe0a5d97
|
90
|
|
Activation of Antioxidant and Proteolytic Pathways in the Nigrostriatal Dopaminergic System After 3,4-Methylenedioxymethamphetamine Administration: Sex-Related Differences, file e2f56eda-2ca0-3eaf-e053-3a05fe0a5d97
|
86
|
|
Modulation of rat 50-kHz ultrasonic vocalizations by glucocorticoid signaling: possible relevance to reward and motivation, file e2f56ed7-290f-3eaf-e053-3a05fe0a5d97
|
81
|
|
Neurochemical and Behavioral Characterization after Acute and Repeated Exposure to Novel Synthetic Cannabinoid Agonist 5-MDMB-PICA, file e2f56ed9-5da4-3eaf-e053-3a05fe0a5d97
|
74
|
|
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates, file e2f56eda-01d2-3eaf-e053-3a05fe0a5d97
|
69
|
|
Mouse and rat ultrasonic vocalizations in neuroscience and neuropharmacology: State of the art and future applications, file 6b237dea-ab4f-45f8-a66b-cdec065dc1e0
|
64
|
|
Gender Differences in Neurodegeneration, Neuroinflammation and Na+-Ca2+ Exchangers in the Female A53T Transgenic Mouse Model of Parkinson’s Disease, file e2f56ed9-28a4-3eaf-e053-3a05fe0a5d97
|
61
|
|
Association between novel object recognition/spontaneous alternation behavior and emission of ultrasonic vocalizations in rats: Possible relevance to the study of memory, file e2f56eda-263a-3eaf-e053-3a05fe0a5d97
|
39
|
|
Editorial: The toxicology of drugs of abuse, file edf27cd1-3e27-45e2-852d-bcb0998690cc
|
29
|
|
Rat ultrasonic vocalizations and behavioral neuropharmacology: from the screening of drugs to the study of disease, file 8686d19a-b446-43b4-9949-f6ccedf362fd
|
24
|
|
Brain dysfunctions and neurotoxicity induced by psychostimulants in experimental models and humans: an overview of recent findings, file 68dd5563-43fd-4f3c-b341-4690891d3252
|
20
|
|
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex, file c7019803-f504-490f-b60c-68ce13eb7330
|
17
|
|
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex, file f427bc96-de82-422f-b432-ca75c4ae6f0f
|
16
|
|
Dopaminergic neurodegeneration in a rat model of long-term hyperglycemia: preferential degeneration of the nigrostriatal motor pathway, file e2f56ed7-8b00-3eaf-e053-3a05fe0a5d97
|
12
|
|
Rat ultrasonic vocalizations and behavioral neuropharmacology: from the screening of drugs to the study of disease, file e2f56ed4-57a1-3eaf-e053-3a05fe0a5d97
|
8
|
|
In utero exposure to dexamethasone causes a persistent and age-dependent exacerbation of the neurotoxic effects and glia activation induced by MDMA in dopaminergic brain regions of C57BL/6J mice, file e2f56eda-08ed-3eaf-e053-3a05fe0a5d97
|
8
|
|
Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson's disease, file e2f56ed4-5a54-3eaf-e053-3a05fe0a5d97
|
7
|
|
Activation of adenosine A2A receptors suppresses the emission of pro-social and drug-stimulated 50-kHz ultrasonic vocalizations in rats: possible relevance to reward and motivation, file e2f56ed4-eca9-3eaf-e053-3a05fe0a5d97
|
7
|
|
Adenosine A2A receptors: localization and function, file e2f56ed4-537e-3eaf-e053-3a05fe0a5d97
|
6
|
|
Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: comparison of the effects of different psychoactive drugs and relevance in drug-induced reward, file e2f56ed4-5470-3eaf-e053-3a05fe0a5d97
|
6
|
|
Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l-DOPA-induced rotational behavior in a rodent model of Parkinson's disease, file e2f56ed4-57a0-3eaf-e053-3a05fe0a5d97
|
6
|
|
Repeated amphetamine administration and long-term effects on 50-kHz ultrasonic vocalizations: possible relevance to the motivational and dopamine-stimulating properties of the drug, file e2f56ed4-5967-3eaf-e053-3a05fe0a5d97
|
6
|
|
Ultrasonic vocalizations as a tool in studying emotional states in rodent models of social behavior and brain disease, file e2f56ed8-c18a-3eaf-e053-3a05fe0a5d97
|
6
|
|
Elevation of striatal urate in experimental models of Parkinson's disease: a compensatory mechanism triggered by dopaminergic nigrostriatal degeneration?, file e2f56ed4-587c-3eaf-e053-3a05fe0a5d97
|
5
|
|
Dyskinesia in Parkinson's disease: mechanisms and current non-pharmacological interventions, file e2f56ed4-587f-3eaf-e053-3a05fe0a5d97
|
5
|
|
Role of Adenosine in the basal Ganglia, file e2f56ed6-0676-3eaf-e053-3a05fe0a5d97
|
5
|
|
Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms, file e2f56ed6-a496-3eaf-e053-3a05fe0a5d97
|
5
|
|
Repertoire and Biological Function of Ultrasonic Vocalizations in Adolescent and Adult Rats, file e2f56ed7-bc4a-3eaf-e053-3a05fe0a5d97
|
5
|
|
The 6-hydroxydopamine model of Parkinson's disease, file e2f56ed4-11b8-3eaf-e053-3a05fe0a5d97
|
4
|
|
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease, file e2f56ed4-51eb-3eaf-e053-3a05fe0a5d97
|
4
|
|
Perinatal asphyxia: current status and approaches towards neuroprotective strategies, with focus on sentinel proteins, file e2f56ed4-5261-3eaf-e053-3a05fe0a5d97
|
4
|
|
L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies, file e2f56ed4-53e8-3eaf-e053-3a05fe0a5d97
|
4
|
|
Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons, file e2f56ed4-5465-3eaf-e053-3a05fe0a5d97
|
4
|
|
Protective Agents in Parkinson's Disease: Caffeine and Adenosine A2A Receptor Antagonists, file e2f56ed4-58f3-3eaf-e053-3a05fe0a5d97
|
4
|
|
Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility, file e2f56ed4-5bac-3eaf-e053-3a05fe0a5d97
|
4
|
|
Repeated Administration of 3,4-Methylenedioxymethamphetamine (MDMA) Elevates the Levels of Neuronal Nitric Oxide Synthase in the Nigrostriatal System: Possible Relevance to Neurotoxicity, file e2f56ed7-d3c6-3eaf-e053-3a05fe0a5d97
|
4
|
|
Characterization Of The Neurochemical And Behavioral Effects Of The Phenethylamine 2-Cl-4,5-Mdma In Adolescent And Adult Male Rats, file 3ade29f5-313f-4043-993a-923addd11f10
|
3
|
|
Strain dependence of adolescent Cannabis influence on heroin reward and mesolimbic dopamine transmission in adult Lewis and Fischer 344 rats, file e2f56ed4-5403-3eaf-e053-3a05fe0a5d97
|
3
|
|
Alteration in the progression of dopamine neuron degeneration: May caffeine offer new perspective?, file e2f56ed4-5472-3eaf-e053-3a05fe0a5d97
|
3
|
|
Methylxanthines and Drug Dependence: A Focus on Interactions with Substances of Abuse, file e2f56ed4-56d3-3eaf-e053-3a05fe0a5d97
|
3
|
|
MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex, file e2f56ed4-57af-3eaf-e053-3a05fe0a5d97
|
3
|
|
Ultrasonic vocalizations in rats: a tool for the investigation of psychoactive drugs and neuropsychiatric conditions, file e2f56ed4-586f-3eaf-e053-3a05fe0a5d97
|
3
|
|
What do you see as the main priorities, Opportunities, and Challenges in Caffeine Research in the Next Five Years?, file e2f56ed4-597b-3eaf-e053-3a05fe0a5d97
|
3
|
|
Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat, file e2f56ed4-5a57-3eaf-e053-3a05fe0a5d97
|
3
|
|
Dopaminergic Treatments for Parkinson’s Disease: Light and Shadows, file e2f56ed4-7a54-3eaf-e053-3a05fe0a5d97
|
3
|
|
Methylxanthines and drug dependence: interactions and toxicity, file e2f56ed5-2986-3eaf-e053-3a05fe0a5d97
|
3
|
|
Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brain, file e2f56ed5-31a8-3eaf-e053-3a05fe0a5d97
|
3
|
|
Effects of Psychostimulants on Rat Emotional States and Emission of Ultrasonic Vocalizations, file e2f56ed7-a4f2-3eaf-e053-3a05fe0a5d97
|
3
|
|
Role of adenosine A2A receptors in motor control: relevance to Parkinson’s disease and dyskinesia, file e2f56ed7-bf0b-3eaf-e053-3a05fe0a5d97
|
3
|
|
The novel psychoactive substance methoxetamine induces persistent behavioral abnormalities and neurotoxicity in rats, file e2f56ed8-143f-3eaf-e053-3a05fe0a5d97
|
3
|
|
Anti-HIV drugs promote β-amyloid deposition and impair learning and memory in BALB/c mice, file e2f56ed9-60dc-3eaf-e053-3a05fe0a5d97
|
3
|
|
Lack of drug- and cue-stimulated emissions of ultrasonic vocalizations in C57BL/6 J mice repeatedly treated with amphetamine, file e2f56ed9-cf07-3eaf-e053-3a05fe0a5d97
|
3
|
|
Protective Agents in Parkinson’s Disease: Caffeine and Adenosine A2A Receptor Antagonists, file e2f56eda-8245-3eaf-e053-3a05fe0a5d97
|
3
|
|
Influence of repeated exposure to caffeine on dopamine transmission: preclinical evidence and potential consequences of caffeine consumption, file e2f56ed3-9efe-3eaf-e053-3a05fe0a5d97
|
2
|
|
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug, file e2f56ed4-54e8-3eaf-e053-3a05fe0a5d97
|
2
|
|
Antagonism of Adenosine A1 or A2A Receptors Amplifies the Effects of 3,4-Methylendioxymethamphetamine (MDMA) on Glial Activation in the Mouse Brain: Relevance to Caffeine-MDMA Interactions, file e2f56ed4-5876-3eaf-e053-3a05fe0a5d97
|
2
|
|
Contribution of Caffeine to the Psychostimulant, Neuroinflammatory and Neurotoxic Effects of Amphetamine-Related Drugs, file e2f56ed4-58fa-3eaf-e053-3a05fe0a5d97
|
2
|
|
Anxyiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABAA receptor activity, file e2f56ed4-59e6-3eaf-e053-3a05fe0a5d97
|
2
|
|
Adenosine A2A receptor antagonists and Parkinson’s disease: state of the art and future directions, file e2f56ed4-5a5b-3eaf-e053-3a05fe0a5d97
|
2
|
|
Priming of rotational behavior by a dopamine receptor agonist in hemiparkinsonian rats: Movement-dependent induction, file e2f56ed4-5a5d-3eaf-e053-3a05fe0a5d97
|
2
|
|
Anxiolytic-like effects of N,N-dialkyl-2-phenylindol-3-ylglyoxylamides by modulation of translocator protein promoting neurosteroid biosynthesis, file e2f56ed4-5ac0-3eaf-e053-3a05fe0a5d97
|
2
|
|
Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats, file e2f56ed4-5ac2-3eaf-e053-3a05fe0a5d97
|
2
|
|
Striatal neuroprotection with methylene blue, file e2f56ed4-5bb3-3eaf-e053-3a05fe0a5d97
|
2
|
|
Blockade of globus pallidus adenosine A2A receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D1 or D2 dopamine receptor agonists, file e2f56ed4-5c17-3eaf-e053-3a05fe0a5d97
|
2
|
|
Increase of dopamine D2(High) receptors in the striatum of rats sensitized to caffeine motor effects, file e2f56ed4-5c19-3eaf-e053-3a05fe0a5d97
|
2
|
|
Symptomatic and Neuroprotective Effects of A2A Receptor Antagonists in Parkinson’s Disease, file e2f56ed4-64e6-3eaf-e053-3a05fe0a5d97
|
2
|
|
Amphetamine usage, misuse, and addiction processes: an overview, file e2f56ed4-f957-3eaf-e053-3a05fe0a5d97
|
2
|
|
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease, file e2f56ed5-122f-3eaf-e053-3a05fe0a5d97
|
2
|
|
Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence, file e2f56ed6-dcfd-3eaf-e053-3a05fe0a5d97
|
2
|
|
Emission of categorized 50-kHz ultrasonic vocalizations in rats repeatedly treated with amphetamine or apomorphine: possible relevance to drug-induced modifications in the emotional state, file e2f56ed7-7c86-3eaf-e053-3a05fe0a5d97
|
2
|
|
Rat 50-kHz ultrasonic vocalizations as a tool in studying neurochemical mechanisms that regulate positive emotional states, file e2f56ed8-3242-3eaf-e053-3a05fe0a5d97
|
2
|
|
Effect of long-term administration of antiretroviral drugs (Tenofovir and Nevirapine) on neuroinflammation and neuroplasticity in mouse hippocampi, file e2f56ed8-4d89-3eaf-e053-3a05fe0a5d97
|
2
|
|
Influence of dopamine transmission in the medial prefrontal cortex and dorsal striatum on the emission of 50-kHz ultrasonic vocalizations in rats treated with amphetamine: Effects on drug-stimulated and conditioned calls, file e2f56ed8-bcbb-3eaf-e053-3a05fe0a5d97
|
2
|
|
Effects of combination antiretroviral drugs (cART) on hippocampal neuroplasticity in female mice, file e2f56eda-045d-3eaf-e053-3a05fe0a5d97
|
2
|
|
Editorial of special issue – Synthetic psychoactive substances and neurological diseases: Toxic and therapeutic effects, file e2f56eda-2e0e-3eaf-e053-3a05fe0a5d97
|
2
|
|
Divergent acute and enduring changes in 50-kHz ultrasonic vocalizations in rats repeatedly treated with amphetamine and dopaminergic antagonists: new insights on the role of dopamine in calling behavior, file 140d6ab8-6abb-4425-a049-34fe3206a76b
|
1
|
|
null, file d94434f1-7985-45db-9b5d-5d1e2e1f85cb
|
1
|
|
Can dietary substances protect against Parkinson's disease? The case of caffeine, file e2f56ed4-56d7-3eaf-e053-3a05fe0a5d97
|
1
|
|
Pharmacological therapy of Parkinson's disease: current options and new avenues, file e2f56ed4-5a49-3eaf-e053-3a05fe0a5d97
|
1
|
|
Nicotinamide prevents the long-term effects of perinatal asphyxia on apoptosis, non-spatial working memory and anxiety in rats, file e2f56ed4-5a52-3eaf-e053-3a05fe0a5d97
|
1
|
|
Acute perinatal asphyxia impairs non-spatial memory and alters motor coordination in adult male rats, file e2f56ed4-5c23-3eaf-e053-3a05fe0a5d97
|
1
|
|
null, file e2f56ed4-5c97-3eaf-e053-3a05fe0a5d97
|
1
|
|
Preface [ to The Adenosinergic System. A Non-Dopaminergic Target in Parkinson’s Disease], file e2f56ed4-dae5-3eaf-e053-3a05fe0a5d97
|
1
|
|
Progression and Persistence of Neurotoxicity Induced by MDMA in Dopaminergic Regions of the Mouse Brain and Association with Noradrenergic, GABAergic, and Serotonergic Damage, file e2f56ed6-d6e0-3eaf-e053-3a05fe0a5d97
|
1
|
|
Unbinding of Translocator Protein 18 kDa (TSPO) Ligands: From in Vitro Residence Time to in Vivo Efficacy via in Silico Simulations, file e2f56ed8-b4a7-3eaf-e053-3a05fe0a5d97
|
1
|
|
Increased emissions of 50-kHz ultrasonic vocalizations in hemiparkinsonian rats repeatedly treated with dopaminomimetic drugs: A potential preclinical model for studying the affective properties of dopamine replacement therapy in Parkinson's disease, file e2f56eda-006c-3eaf-e053-3a05fe0a5d97
|
1
|
| Totale |
3.509 |